High expression of PYK2 is associated with poor prognosis and cancer progression in early-stage cervical carcinoma

Medicine (Baltimore). 2022 Oct 14;101(41):e31178. doi: 10.1097/MD.0000000000031178.

Abstract

Proline-rich tyrosine kinase-2 (PYK2), also known as calcium dependent tyrosine kinase, regulates different signal transduction cascades that control cell proliferation, migration, and invasion. However, the role of PYK2 in cervical cancer remains to be elucidated. The current study retrospectively included 134 patients with cervical cancer from December 2007 to September 2014. PYK2 expression was detected in tissue microarray and cervical cancer cell lines. Statistical analysis was performed to evaluate its clinicopathological significance. Small interfering RNA (siRNA) was employed to suppress endogenous PYK2 expression in cervical cancer cells to observe the biological function. PYK2 expression was up-regulated in cervical cancer specimens compared with paired adjacent normal cervical tissue samples. Statistical analyses indicated that PYK2 expression might be an independent prognostic indicator for patients with early-stage cervical cancer. A nomogram model was constructed based on PYK2 expression and other clinicopathological risk factors, and it performed well in predicting patients survival. In cellular studies, down-regulation of PYK2 remarkably inhibited cellular proliferation, migration and invasion. PYK2 expression possessed the potential to serve as a novel prognostic marker in cervical cancer patients.

MeSH terms

  • Calcium
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Female
  • Focal Adhesion Kinase 2* / genetics
  • Focal Adhesion Kinase 2* / metabolism
  • Humans
  • Prognosis
  • Proline
  • RNA, Small Interfering
  • Retrospective Studies
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Calcium
  • Focal Adhesion Kinase 2
  • Proline
  • RNA, Small Interfering
  • PTK2B protein, human